• Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond

  • Oct 16 2024
  • Length: 40 mins
  • Podcast

Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond

Listen for free

View show details

  • Summary

  • October 15, 2024 | In this month’s episode of The Chain, host Rakesh Dixit, PhD, DABT, president and founder of Bionavigen Oncology and Regio Biosciences, and John Lambert, PhD, consultant, about antibody drug conjugates (ADCs) then, now, and beyond. Lambert shares his experiences from his decades-long career at ImmunoGen, why ADCs are more successful now compared to in the past, and where he sees ADCs going forward. He also discusses his thoughts on the half-life of diffusible payloads, the toxicity of the bystander effect, and more.

    LINKS:
    Bionavigen
    ImmunoGen

    Show more Show less
Show more Show less

What listeners say about Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available